Geraldine Kaeslin

572 total citations
6 papers, 302 citations indexed

About

Geraldine Kaeslin is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Geraldine Kaeslin has authored 6 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Nephrology and 2 papers in Immunology. Recurrent topics in Geraldine Kaeslin's work include Complement system in diseases (2 papers), Receptor Mechanisms and Signaling (2 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). Geraldine Kaeslin is often cited by papers focused on Complement system in diseases (2 papers), Receptor Mechanisms and Signaling (2 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). Geraldine Kaeslin collaborates with scholars based in Australia, United States and United Kingdom. Geraldine Kaeslin's co-authors include Matthew A. Cooper, Mark A. T. Blaskovich, Daniel E. Croker, Mark S. Butler, Reena Halai, Peter N. Monk, Ruby Pelingon, Johnny X. Huang, Beate Fehlhaber and Andreas Klos and has published in prestigious journals such as European Journal of Medicinal Chemistry, Immunology and Cell Biology and ACS Medicinal Chemistry Letters.

In The Last Decade

Geraldine Kaeslin

6 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geraldine Kaeslin Australia 6 140 113 32 29 26 6 302
Valentin Schatz Germany 14 97 0.7× 99 0.9× 19 0.6× 22 0.8× 5 0.2× 20 419
Elisabetta Sinigaglia Italy 7 135 1.0× 53 0.5× 4 0.1× 33 1.1× 5 0.2× 8 363
Mehdi Amiri Canada 12 373 2.7× 47 0.4× 10 0.3× 22 0.8× 14 0.5× 29 518
Dhia Azzouz Canada 8 110 0.8× 197 1.7× 8 0.3× 30 1.0× 3 0.1× 8 307
Malvina Pizzuto Belgium 11 228 1.6× 133 1.2× 10 0.3× 24 0.8× 2 0.1× 13 357
Jin Zhao China 11 156 1.1× 38 0.3× 4 0.1× 38 1.3× 3 0.1× 50 362
Jijun Yuan China 11 240 1.7× 14 0.1× 24 0.8× 7 0.2× 13 0.5× 22 354
Xi Zhao China 9 194 1.4× 20 0.2× 8 0.3× 16 0.6× 4 0.2× 21 390
Arun Surendran India 13 188 1.3× 26 0.2× 4 0.1× 67 2.3× 19 0.7× 30 444
Shinobu Miyazawa Japan 7 141 1.0× 104 0.9× 49 1.5× 64 2.2× 5 0.2× 10 371

Countries citing papers authored by Geraldine Kaeslin

Since Specialization
Citations

This map shows the geographic impact of Geraldine Kaeslin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geraldine Kaeslin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geraldine Kaeslin more than expected).

Fields of papers citing papers by Geraldine Kaeslin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geraldine Kaeslin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geraldine Kaeslin. The network helps show where Geraldine Kaeslin may publish in the future.

Co-authorship network of co-authors of Geraldine Kaeslin

This figure shows the co-authorship network connecting the top 25 collaborators of Geraldine Kaeslin. A scholar is included among the top collaborators of Geraldine Kaeslin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geraldine Kaeslin. Geraldine Kaeslin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Phetsang, Wanida, Ruby Pelingon, Mark S. Butler, et al.. (2016). Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coli. ACS Infectious Diseases. 2(10). 688–701. 45 indexed citations
2.
Croker, Daniel E., Peter N. Monk, Reena Halai, et al.. (2016). Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling. Immunology and Cell Biology. 94(8). 787–795. 60 indexed citations
3.
Salla, Manohar, Mark S. Butler, Ruby Pelingon, et al.. (2016). Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950. ACS Medicinal Chemistry Letters. 7(12). 1034–1038. 40 indexed citations
4.
Huang, Johnny X., Geraldine Kaeslin, Max V. Ranall, et al.. (2015). Evaluation of biomarkers for in vitro prediction of drug‐induced nephrotoxicity: comparison ofHK‐2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells. Pharmacology Research & Perspectives. 3(3). e00148–e00148. 52 indexed citations
5.
Jarrad, Angie M., Tomislav Karoli, Anjan Debnath, et al.. (2015). Metronidazole-triazole conjugates: Activity against Clostridium difficile and parasites. European Journal of Medicinal Chemistry. 101. 96–102. 50 indexed citations
6.
Croker, Daniel E., Reena Halai, Geraldine Kaeslin, et al.. (2014). C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β‐arrestin recruitment. Immunology and Cell Biology. 92(7). 631–639. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026